CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Instituto de Física de São Carlos (IFSC) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Generalist Pharmacist graduated with the "Paulo Minami Award" for best student in 2010 (Centro Universitário de Araraquara UNIARA). After graduation, she worked as a quality control analyst in renowned companies within the pharmaceutical and veterinary sectors. She completed her Master's and Ph.D. in Pharmaceutical Sciences at São Paulo State University Júlio de Mesquita Filho (UNESP), Faculty of Pharmaceutical Sciences, including a research internship abroad at the Life and Health Sciences Research Institute (ICVS) at the School of Medicine, University of Minho, Braga, Portugalan excellence center in health sciences, medical innovation, and specialized services, supported by the São Paulo Research Foundation (FAPESP).Throughout the academic journey, she contributed to training qualified human resources and received awards for her work at national and international scientific events. With a keen scientific spirit, in 2021, she was selected for nomination for the CAPES Thesis Award 2020 by the Graduate Program in Pharmaceutical Sciences at FCFAR-UNESP. From 2020 to 2024, she held a Postdoctoral Fellowship (FAPESP 2019/25645-0) at the São Carlos Institute of Physics (IFSC), Nanomedicine and Nanotoxicology Group (GNano), focusing on the following themes: nanotechnology, drug delivery systems, development of new materials, polymeric nanoparticles, biomimetic and bioinspired nanosystems, nasal drug administration, cancer treatment, and COVID-19.She won the USP Researcher Mothers Award in the Postdoctoral category (2022) and the Veja Saúde Oncoclínicas Medical Innovation Award (2024). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Glioblastoma (GBM) account for 77% of malignant tumors that occur in the central nervous system (SNC) and, currently, despite all the developments in chemotherapy, radiotherapy, and neurosurgery, GBM still has limited prognosis. The existence of physiological barriers, especially blood brain barriers (BBB), represents the main obstacle that limits adequate concentrations of different drug…
Glioblastomas (GBM) account 77% of malignant tumors that occurs on central nervous system (SNC) and today, despite all advances in chemotherapy, radiotherapy and neurosurgery, remains with limited prognoses. The existence of physiological barriers, especially blood brain barrier (BBB), represents the main obstacle that limits appropriate concentrations of the drugs designed to GBM therapy…
Cancer is a global problem responsible for approximately 13% of deaths worldwide. The process of angiogenesis plays an essential role in tumor growth, invasion and metastasis. Among the growth factors and cytokines related to this process, Vascular Endothelial Growth Factor (VEGF) is presented as a key aspect in pathological situations involving neovascularization such as cancer. Bevacizu…
Glioblastomas (GBM) account 77% of malignant tumors that occurs on central nervous system (SNC) and today, despite all advances in chemotherapy, radiotherapy and neurosurgery, remains with limited prognosis. The existence of physiological barriers, especially blood brain barrier (BBB), represents the main obstacle that limits adequate concentrations of the drugs designed to therapy. Due t…
Angiogenesis process plays an important role in tumor growth, invasion and metastasis. Vascular Endothelial Growth Factor (VEGF) appears as a key in pathological situations involving neovascularization. Bevacizumab (BVZ) is a monoclonal antibody that acts against angiogenesis process which accompanies tumor tissue, resulting in inhibition of necessary supply for tumor cells development. F…
| 3 / 3 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 5 / 5 | All Scholarships |
| Associated processes | |